Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Non-toxic clostridium perfringens beta-toxin genetic engineering vaccine and production method thereof

A technology of Clostridium perfringens and genetic engineering vaccine, which is applied in the fields of genetic engineering, biochemical equipment and methods, plant gene improvement, etc., can solve the problems affecting the expression level of fusion protein and the reduction of effective antigenic components of fusion protein, and achieves Avoid the effect of immunogenicity of antigenic protein, reduce preparation time and production cost, avoid effect

Inactive Publication Date: 2019-05-03
CHINA INST OF VETERINARY DRUG CONTROL
View PDF2 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Since the MBP tag has a larger protein molecular weight (40kDa), the effective antigenic component of the fusion protein is reduced and may affect the expression level of the fusion protein

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Non-toxic clostridium perfringens beta-toxin genetic engineering vaccine and production method thereof
  • Non-toxic clostridium perfringens beta-toxin genetic engineering vaccine and production method thereof
  • Non-toxic clostridium perfringens beta-toxin genetic engineering vaccine and production method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0076] ——Construction, expression and identification of Escherichia coli BL / SUB strain

[0077] 1. Gene synthesis

[0078] According to the sequence of the natural protein gene of Clostridium perfringens β toxin, the application designed 4 amino acid mutations after codon optimization, and the 212th arginine in the mature toxin of the wild type Clostridium perfringens β toxin Acid is mutated to glutamic acid, leucine at position 268 is mutated to glycine, tyrosine at position 266 and tryptophan at position 278 are mutated to alanine, thus obtaining a beta toxin mutant that is non-toxic to animals . At the same time, a SUMO tag and a 6×His tag were added to the N-terminal and C-terminal, respectively. The gene sequence GSUMO-CPB was synthesized by chemical synthesis m4 , containing a total of 1296 nucleotides. The specific nucleic acid sequence is shown in SEQ ID No.1, and the amino acid sequence is shown in SEQ ID No.2.

[0079] 2. Construction of fusion expression vector...

Embodiment 2

[0090] - Expression and identification of target genes

[0091] 1. Expression of target protein

[0092] Inoculate the recombinant Escherichia coli (E.coli) BL / SUB strain in 4 mL of LB liquid medium containing kanamycin, and shake at 37°C for OD 600 When the temperature is 0.6-0.8, lower the temperature to 15°C, and add IPTG solution with a final concentration of 0.5mmol / L to induce culture for 16h. After the bacterial culture was completed, the bacterial cells were collected by centrifugation, and the bacterial cells were resuspended at a ratio of 10 mL of lysate [0.02 mol / L Tris buffer (pH 7.2), 0.3 mol / L NaCl] per gram of bacterial body weight, and placed in an ice-water bath. The bacteria were disrupted by ultrasonic for 30 minutes, the crushing conditions were: working for 9s, resting for 9s, and the ultrasonic power was 400W. The crushed bacterial liquid was centrifuged at 12000r / min for 10min at 4°C, and the supernatant was collected. Take 30 μL of the supernatant an...

Embodiment 3

[0096] ——rSUMO-CPB m4 purification of

[0097] Inoculate the recombinant Escherichia coli (E.coli) BL / SUB strain in 1L LB liquid medium containing kanamycin for fermentation culture, shake culture at 37°C OD 600 When the temperature is 0.6-0.8, lower the temperature to 15°C, and add IPTG solution with a final concentration of 0.5mM to induce culture for 16h. After the bacterial culture was completed, the bacterial cells were collected by centrifugation, and the supernatant was collected according to the method in step 4. From the supernatant collected in the above step 4, purify the soluble expressed target protein in the cell lysate supernatant according to the instruction manual of the Ni-IDA affinity chromatography medium kit, and filter it through a 0.22 μm pore size filter membrane to obtain Primary purified target protein rSUMO-CPB m4 .

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to a non-toxic clostridium perfringens beta-toxin genetic engineering vaccine. The prepared clostridium perfringens beta-toxin recombinant subunit vaccine is produced bycodon-optimized production and multiple-amino-acid-mutation- containing recombinant clostridium perfringens beta-toxin proteins, thus maximally retains integrity and spatial conformation of natural toxin proteins, keeps immunogenicity, and also avoids biosafety hazards brought by single amino acid mutations. The vaccine also has advantages of simple preparation technology, low immune dose, excellent vaccine efficacy, etc., greatly reduces biosafety risks in vaccine production processes compared with current commercial clostridium perfringens natural toxin inactivated vaccines in China, and isan ideal candidate vaccine for upgrading of current type B and type C clostridium perfringens toxin vaccines in China; and when the vaccine and other antigens are commonly used to prepare a combined vaccine, dose of the combined vaccine cannot be increased and the combined vaccine can be prepared.

Description

technical field [0001] The invention relates to an avirulent Clostridium perfringens beta toxin genetic engineering vaccine and a production method thereof. It belongs to the field of veterinary biological products. Background technique [0002] Clostridium perfringens is an important zoonotic disease, among which, lamb dysentery, necrotic enteritis of cattle and sheep, enterotoxemia of cattle and sheep, and swine dysentery are the most harmful to animal husbandry. The bacteria mainly cause disease through the exotoxins it secretes. According to the types of four main lethal exotoxins α, β, γ and ι produced, the bacteria are divided into five toxin types: A, B, C, D, and E. Clostridium perfringens has the characteristics of acute onset, short course of disease and high mortality rate. Once the onset occurs, sudden death often occurs due to exotoxin poisoning before treatment. Therefore, immunization is an effective way to prevent and control the disease. [0003] The curre...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K39/08A61P31/04C12N15/31C07K14/33
Inventor 陈小云杜吉革刘莹薛麒朱真印春生李启红康凯姚文生
Owner CHINA INST OF VETERINARY DRUG CONTROL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com